122 related articles for article (PubMed ID: 26266196)
1. A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.
Komaram RB; Nukala S; Palla J; Nambaru LR; Kasturi SM
J Clin Diagn Res; 2015 Jun; 9(6):VC05-VC08. PubMed ID: 26266196
[TBL] [Abstract][Full Text] [Related]
2. Early effect on general interest, and short-term antidepressant efficacy and safety of agomelatine (25-50mg/day) and escitalopram (10-20mg/day) in outpatients with Major Depressive Disorder. A 12-week randomised double-blind comparative study.
Udristoiu T; Dehelean P; Nuss P; Raba V; Picarel-Blanchot F; de Bodinat C
J Affect Disord; 2016 Jul; 199():6-12. PubMed ID: 27054610
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the clinical efficacy and safety of agomelatine with escitalopram in major depressive disorder patients: A randomized, parallel-group, phase IV study.
Urade CS; Mahakalkar SM; Tiple PG
J Pharmacol Pharmacother; 2015; 6(4):198-203. PubMed ID: 26813706
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine.
Li Z; Wu TT; Xiong YT; Zhang XY; Bao YP; Guo LB; Han BJ; Li SX; Wang YF; Lu L; Wang XQ
Front Psychiatry; 2023; 14():1188175. PubMed ID: 37426111
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
Schmitt L; Arbus C; Tonnoir B
Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
[TBL] [Abstract][Full Text] [Related]
8. Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France.
Gorwood P; Benichou J; Moore N; Wattez M; Secouard MC; Desobry X; Picarel-Blanchot F; de Bodinat C
Clin Drug Investig; 2020 Nov; 40(11):1009-1020. PubMed ID: 32729068
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
Colonna L; Andersen HF; Reines EH
Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
[TBL] [Abstract][Full Text] [Related]
10. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of agomelatine in epilepsy patients with sleep and mood disorders: An observational, retrospective cohort study.
Jiang J; Wu YJ; Yan CH; Jin Y; Yang TT; Han T; Liu XW
Epilepsy Behav; 2024 Mar; 152():109641. PubMed ID: 38286099
[TBL] [Abstract][Full Text] [Related]
13. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
14. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study.
Jeong JH; Bahk WM; Woo YS; Lee KU; Kim DH; Kim MD; Kim W; Yang JC; Lee KH
Neuropsychiatr Dis Treat; 2015; 11():2557-64. PubMed ID: 26504387
[TBL] [Abstract][Full Text] [Related]
17. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
DeMartinis NA; Yeung PP; Entsuah R; Manley AL
J Clin Psychiatry; 2007 May; 68(5):677-88. PubMed ID: 17503976
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study.
Emsley R; Ahokas A; Suarez A; Marinescu D; Dóci I; Lehtmets A; Milanova V; Lee MS; Didi R; Araszkiewicz A; Sulaiman AH; Blanchot FP; Crutel VS; Antoine C; Penelaud PF
J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 29995359
[TBL] [Abstract][Full Text] [Related]
20. Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks Follow-up Study on Efficacy and Tolerability.
Akpınar E; Cerit C; Talas A; Tural Ü
Clin Psychopharmacol Neurosci; 2016 Nov; 14(4):351-356. PubMed ID: 27776387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
